Multicenter phase II trial of temozolomide (TMZ) and rituximab (RIT) for recurrent primary CNS lymphoma (PCNSL): North American Brain Tumor Consortium (NABTC) study 05-01 Meeting Abstract

  

Authors:	Nayak, L.; Abrey, L. E.; Drappatz, J.; Gilbert, M. R.; Reardon, D. A.; Lamborn, K.; Wen, P. Y.; Prados, M.; DeAngelis, L. M.; Omuro, A. M. P.
Abstract Title:	Multicenter phase II trial of temozolomide (TMZ) and rituximab (RIT) for recurrent primary CNS lymphoma (PCNSL): North American Brain Tumor Consortium (NABTC) study 05-01
Meeting Title:	47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	29
Issue:	15 Suppl.
Meeting Dates:	2011 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2011-05-20
Language:	English
ACCESSION:	WOS:000208880301255
DOI:	10.1200/jco.2011.29.15_suppl.2039
PROVIDER:	wos
Notes:	Meeting Abstract: 2039 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/141497